Rho Capital Partners

Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are IL, Everyday Health, Anacor Pharmaceuticals In, Cara Therapeutics, Nephrogenex. These five stock positions account for 96.08% of RHO CAPITAL PARTNERS's total stock portfolio.
  • Reduced shares in these 1 stocks: Everyday Health (-$26.56M).
  • As of Dec. 31, 2014, RHO CAPITAL PARTNERS has $225.42M in assets under management (AUM). Assets under management grew from a total value of $199.12M to $225.42M.
  • Independent of market fluctuations, RHO CAPITAL PARTNERS was a net seller by $26.56M worth of stocks in the most recent quarter.

RHO CAPITAL PARTNERS portfolio companies for December 2014 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
IL IntraLinks Holdings 34.26 6490503 11.90 10.71
Everyday Health 26.88 -30.00% 4107522 14.75 0.00
Anacor Pharmaceuticals In 15.28 1067892 32.25 0.00
Cara Therapeutics 11.80 2668057 9.97 0.00
Nephrogenex 7.86 1326826 13.35 0.00
RLOC ReachLocal 3.92 2570395 3.44 2.96

Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS

View All Filings for RHO CAPITAL PARTNERS